Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis.
- DOI
- 10.1016/j.carrev.2026.08.004
- Published
- 2026 Aug 13
- Container
- Cardiovascular revascularization medicine : including molecular interventions
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.carrev.2026.08.004,
title = {Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis.},
author = {Chinnatambi C and Ottun AR and Sakowski L and Darko P and Otchere B and Mohammed-Murtala AD and Ibrahim S and Klein A and Ibebuogu U and Smith T and Mungee S},
year = {2026},
journal = {Cardiovascular revascularization medicine : including molecular interventions},
doi = {10.1016/j.carrev.2026.08.004},
url = {https://doi.org/10.1016/j.carrev.2026.08.004}
}RIS
TY - JOUR TI - Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis. AU - Chinnatambi C AU - Ottun AR AU - Sakowski L AU - Darko P AU - Otchere B AU - Mohammed-Murtala AD AU - Ibrahim S AU - Klein A AU - Ibebuogu U AU - Smith T AU - Mungee S PY - 2026 JO - Cardiovascular revascularization medicine : including molecular interventions DO - 10.1016/j.carrev.2026.08.004 UR - https://doi.org/10.1016/j.carrev.2026.08.004 ER -
APA
C, C., AR, O., L, S., P, D., B, O., AD, M., S, I., A, K., U, I., T, S., & S, M. (2026). Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis.. Cardiovascular revascularization medicine : including molecular interventions. https://doi.org/10.1016/j.carrev.2026.08.004
Source records
- pubmed · retrieved 2026-09-25T07:27:56.836Z